Crossmark

Synthesis of controlled-size silver nanoparticles for the administration of methotrexate drug and its activity in colon and lung cancer cells

Published Online: 2020

Authors

Rozalen, M. https://orcid.org/0000-0003-3254-1218
Sánchez-Polo, M.

Fernández-Perales, M.

Widmann, T. J.

Rivera-Utrilla, J.
Funding

Funding for this research was provided by:

Ministerio de Ciencia e Innovación (CTQ2016-80978-C2-1-R)
License Information

Version of Record valid from 2020-03-12
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: M. Rozalen (ORCID)

: M. Rozalen (ResearcherID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 22 October 2019; Accepted 17 February 2020; Version of Record published 12 March 2020

Document is current